Camel-derived anti-macrophage immune-activating enzyme antibodies (Canopus)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameCamel-derived anti-macrophage immune-activating enzyme antibodies (Canopus)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionMacrophages inhibitors
TargetsUpdating
Therapy Area/IndicationsShock, Septic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia and New ZealandGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCanopus BioPharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCanopus BioPharma Inc
Active IndicationsN/A
Inactive IndicationsShock, Septic

Other Information

ATC CodeN/A
Related LinksN/A